drugset / Trial / NCT07290777
VEL-101 to Prevent Rejection After Kidney Transplantation
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will evaluate the safety and efficacy of VEL-101 compared with tacrolimus in patients undergoing kidney transplantation.
Timeline
- Start
- 2026-07
- Primary completion
- 2028-10
- Completion
- 2028-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | — | — |
| Subject | pegrizeprument | Monoclonal antibody | — | — |
Indications
No indication recorded.